Impact of Tumor Blood Flow Modulation on Tumor Sensitivity to the Bioreductive Drug Banoxantrone

The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

Jeremy Brown, Amato J. Giaccia · PubMed · 1998 · 1.5K citations

Medicine, Oncology, Pharmacology +16

Rapid vascular regrowth in tumors after reversal of VEGF inhibition

Michael R. Mancuso, Rachel Davis, Scott M. Norberg et al. · Journal of Clinical Investigation · 2006 · 798 citations · Full text

Medicine, Oncology, Pharmacology +14

Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3

Dana D. Hu‐Lowe, Helen Y. Zou, Maren L. Grazzini et al. · Clinical Cancer Research · 2008 · 628 citations

Medicine, Oncology, Pharmacology +17

A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy

Marianne Nordsmark, Jens Overgaard · Radiotherapy and Oncology · 2000 · 281 citations

Medicine, Oncology, Radiation Oncology +15

Reductase Enzyme Expression Across the National Cancer Institute Tumor Cell Line Panel: Correlation With Sensitivity to Mitomycin C and EO9

Sara A. Fitzsimmons, Paul Workman, Michael R. Grever et al. · JNCI Journal of the National Cancer Institute · 1996 · 235 citations · Full text

Life Sciences, Biochemistry, Oncology +17